This statistic compares brand drug prescription revenues of branded and unbranded generics in the United States from 2005 to 2015. In 2005, some 81 percent of total U.S. prescription revenues were made through brand name medications. However, this share decreased to some 71 percent in 2013, and increased slightly to over 74 percent in 2016. Generics are copies or equivalents of once patent protected drugs, containing the same active ingredient, in the same amount, in the same form, dissolving at the same rate in equal amounts like the original.
Proportion of branded versus generic prescription drug revenues in the United States from 2005 to 2016
Exclusive Premium Statistic
This statistic compares brand drug prescription revenues of branded and unbranded generics in the United States from 2005 to 2015. In 2005, some 81 percent of total U.S. prescription revenues were made through brand name medications. However, this share decreased to some 71 percent in 2013, and increased slightly to over 74 percent in 2016. Generics are copies or equivalents of once patent protected drugs, containing the same active ingredient, in the same amount, in the same form, dissolving at the same rate in equal amounts like the original.
More information
Statista Accounts: Access All Statistics. Starting from $588 / Year
Statistics on "Generics and biosimilars"
Statista for Your Company: The Research and Analysis Tool
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Dispensing costs for tablets of generic drugs by public drug plan 2015/16
- Top generics producing companies by prescriptions dispensed 2010
- U.S. spending on multiple sclerosis medicine by type 2010-2014
- U.S. spending growth on new brand specialty medicine by type 2014-2015
- U.S. spending on specialty medicine by type 2012-2016
- U.S. spending on biosimilars by type 2014
- Generic share of dispensed prescriptions by formulation U.S. 2012 vs. 2017
- Number of ANDA approvals in U.S. 2015-2017, by type
- U.S. total vs. generic dispensed prescription numbers 2017, by formulation
- Spending on dispensed total vs. generic prescriptions in the U.S. 2017
- Percentage savings through generic drug usage in the U.S. by payor 2016
- Average number of approved ANDAs per month in U.S. 2009-2017
- Number of approved ANDAs in U.S. 2009-2017
- Average number of ANDAs received per month in U.S. 2009-2017
- Generics prescriptions dispensed in the U.S. 2010-2016
- Value share of generic pharmaceuticals market in Switzerland 2000-2015
- Generic drugs average unit cost index in Canada by public drug plan 2013/2014
- Impact of drug shortages of individual drugs in hospitals on patient care
- Retail sales rate of change generic vs. patented drugs in Canada 2007-2016
- Drugs in R&D pipeline worldwide 2017 vs. 2018, by phase of development
Popular Related Keywords
- brands
- drug
- revenue distribution
- generic drug
- sales
- Show more
- prescription
- drugs
- health
- health service
- branded products
- Pharmaceutical companies
- consumer health care
- healthcare
- generics
- consumer health products
- pharmaceutical products
- pharmaceutical regulations
- brand popularity
- pharmaceutical industry
- generics market
- generics manufacturers
- health sector
- pharmaceutical manufacturers
- retail brand share
- pharmaceutical data
- health market
- pharmaceutical business
- pharmaceutical market
- drug prescription rates